(misoprostol, diclofenac sodium)
Osteoarthritis
Diclofenac sodium, as a single ingredient or in combination with misoprostol, has been shown to be effective in the management of the signs and symptoms of osteoarthritis.
Rheumatoid Arthritis
Diclofenac sodium, as a single ingredient or in combination with misoprostol, has been shown to be effective in the management of the signs and symptoms of rheumatoid arthritis.
Upper Gastrointestinal Safety
Diclofenac, and other NSAIDs, have caused serious gastrointestinal toxicity, such as bleeding, ulceration, and perforation of the stomach, small intestine or large intestine. Misoprostol has been shown to reduce the incidence of endoscopically diagnosed NSAID-induced gastric and duodenal ulcers. In a 12-week, randomized, double-blind, dose-response study, misoprostol 200 mcg administered four, three or two times a day, was significantly more effective than placebo in reducing the incidence of gastric ulcer in osteoarthritis and rheumatoid arthritis patients using a variety of NSAIDs. The three times a day regimen was therapeutically equivalent to misoprostol 200 mcg four times a day with respect to the prevention of gastric ulcers. Misoprostol 200 mcg given two times a day was less effective than 200 mcg given three or four times a day. The incidence of NSAID-induced duodenal ulcer was also significantly reduced with all three regimens of misoprostol compared to placebo (see Table 3).
| Misoprostol 200 mcg Dosage Regimen | ||||
|---|---|---|---|---|
| Placebo | two times a day | three times a day | four times a day | |
| N=1623; 12 weeks | ||||
| ||||
Gastric ulcer | 11% | 6%* | 3%* | 3%* |
Duodenal ulcer | 6% | 2%* | 3%* | 1%* |
Results of a study in 572 patients with osteoarthritis demonstrate that patients receiving ARTHROTEC have a lower incidence of endoscopically defined gastric ulcers compared to patients receiving diclofenac sodium (see Table 4).
| Osteoarthritis patients with history of ulcer or erosive disease (N=572), 6 weeks | Incidence of ulcers | |
|---|---|---|
| Gastric | Duodenal | |
| ||
ARTHROTEC 50 three times a day | 3%* | 6% |
ARTHROTEC 75 two times a day | 4%* | 3% |
Diclofenac sodium 75 mg two times a day | 11% | 7% |
Placebo | 3% | 1% |
MEDICATION GUIDE | |
What is the most important information I should know about ARTHROTEC?
What is the most important information I should know about medicines containing Nonsteroidal Anti-inflammatory Drugs (NSAIDs)?
Do not take NSAID containing medicines right before or after a heart surgery called a "coronary artery bypass graft (CABG)."
The risk of getting an ulcer or bleeding increases with:
| |
|
|
NSAID containing medicines should only be used:
| |
What is ARTHROTEC?
ARTHROTEC is a prescription medicine used to treat:
It is not known if ARTHROTEC is safe and effective for use in children. | |
Who should not take ARTHROTEC?
| |
Before taking ARTHROTEC, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. NSAIDs and some other medicines can interact with each other and cause serious side effects. Do not start taking any new medicine without talking to your healthcare provider first. | |
What are the possible side effects of NSAIDs?
Get emergency help right away if you get any of the following symptoms: | |
|
|
Stop taking your NSAID and call your healthcare provider right away if you get any of the following symptoms: | |
|
|
If you take too much of your NSAID, call your healthcare provider or get medical help right away. | |
Other information about NSAIDs
| |
General information about the safe and effective use of NSAIDs | |
Active ingredients: diclofenac sodium, misoprostol. | |
This Medication Guide has been approved by the U.S. Food and Drug Administration. | Revised: November 2024 |
Additional Resources
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine or vaccine.
Speak with a Pfizer Medical Information Professional regarding your Pfizer medicine or vaccine inquiry.
Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for a Pfizer medicine or a vaccine.
The submission will be reviewed during our standard business hours.
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this medication, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer medication, please call (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or by calling (800) 332-1088.